CTI BIOPHARMA CORP reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Seattle, WA
SEC filing record 1 source field available
Fiscal year end
31 December
CTI BIOPHARMA CORP has filed 2,393 SEC EDGAR filings since 27 Jun 1996

SEC filing history

Showing 1-15 of 15 matching filings.

Per page
25
Current page
1
SC 13D/A File 005-48459

AMENDMENT NO. 9 TO THE SCHEDULE 13D

Filing date
28 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-48459

AMENDMENT NO. 8 TO THE SCHEDULE 13D

Filing date
11 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-48459

GROWTH EQUITY OPPORTUNITIES FUND V, LLC - CTI BIOPHARMA CORP. SCHEDULE 13D/A(#4E

Filing date
22 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-48459

GROWTH EQUITY OPPORTUNITIES FUND V, LLC - CTI BIOPHARMA CORP. SCHEDULE 13D/A(#3)

Filing date
17 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-48459

AMENDMENT NO. 7 TO THE SCHEDULE 13D

Filing date
15 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-48459

GROWTH EQUITY OPPORTUNITIES FUND V, LLC - CTI BIOPHARMA CORP.

Filing date
12 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-48459

AMENDMENT NO. 6 TO THE SCHEDULE 13D

Filing date
04 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-48459

GROWTH EQUITY OPPORTUNITIES FUND V, LLC - CTI BIOPHARMA CORP. -- SCHEDULE 13D/A

Filing date
13 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-48459

AMENDMENT NO. 5 TO THE SCHEDULE 13D

Filing date
04 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-48459

GROWTH EQUITY OPPORTUNITIES FUND V, LLC - CTI BIOPHARMA CORP. -- SCHEDULE 13D

Filing date
20 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-48459

AMENDMENT NO. 4 TO THE SCHEDULE 13D

Filing date
12 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-48459

AMENDMENT NO. 3 TO THE SCHEDULE 13D

Filing date
14 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-48459

AMENDMENT NO. 2 TO THE SCHEDULE 13D

Filing date
14 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-48459

AMENDMENT NO. 1 TO THE SCHEDULE 13D

Filing date
11 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-48459

SCHEDULE 13D

Filing date
11 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .